Factors that Predict Clinical Benefit of EGFR TKI Therapy in Patients with EGFR Wild-Type Lung Adenocarcinoma

by Seo Yun Kim, M.D., Jae Kyung Myung, M.D., Hye-Ryoun Kim, M.D., Im Il Na, M.D., Ph.D., Jae Soo Koh, M.D., Ph.D., Hee Jong Baek, M.D., Ph.D., Cheol Hyeon Kim, M.D., Ph.D.
Published 2019-01-01